Comparison · NCT01585129-aa751feb
Postpartum Antibiotics vs No Postpartum Antibiotics: Number of Participants With Infection-related Complications
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Postpartum Antibiotics vs No Postpartum Antibiotics: Number of Participants With Infection-related Complications. Trial comparisons, record NCT01585129-aa751feb. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01585129-aa751feb
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.171 | 0.0853 | 0.313 | wilson | |
| Risk in group 2 | 0.0513 | 0.0142 | 0.169 | wilson | |
| Risk difference, group 1 minus group 2 | 0.119 | -0.0259 | 0.266 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 3.33 | 0.736 | 15.1 | log | |
| Odds ratio, group 1 over group 2 | 3.81 | 0.74 | 19.6 | log | |
| Number needed to treat, for one more participant with the outcome on Postpartum Antibiotics than on No Postpartum Antibiotics | 8.37 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Postpartum Antibiotics | Patients will receive one additional dose of postpartum antibiotics (Clinda, Gentamicin)~Postpartum Antibiotics: Patients randomized into this arm will receive one additional dose of gentamicin (1.5 mg/kg) and clindamycin (900mg) in the postpartum setting. | 7 | 41 | OG000 |
| Group 2 | No Postpartum Antibiotics | No further postpartum antibiotics~No postpartum antibiotics: Patients randomized into this arm will not receive any postpartum antibiotics after delivery. They will be managed identically to the other arm in terms of chorioamnionitis (fever pre-delivery). The groups will be managed identically if endometritis (post-partum fever) develops. | 2 | 39 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants With Infection-related Complications
- Description
Infection related complications will include common complications attributed to infections there are not the primary outcome (endometritis). This will include infections of the wound and pelvic abscesses.
- Time frame
- 7 days post-partum
- Population
Source ClinicalTrials.gov
Trial
- Title
- Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
- NCT number
- NCT01585129
- Phases
- PHASE4
- Conditions
- The Primary Outcome of This Study Will be the Rate of Endometritis
- Interventions
- Postpartum Antibiotics, No postpartum antibiotics
- Lead sponsor
- Washington University School of Medicine
- Results first posted
- 2018-05-22
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01585129?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01585129-aa751feb